Epilepsy in the Elderly
Open Access
- 1 October 2006
- Vol. 47 (s1) , 65-70
- https://doi.org/10.1111/j.1528-1167.2006.00664.x
Abstract
The elderly are the most rapidly growing segment of the population and the incidence of epilepsy is higher in the elderly than in any other age group. They have been subdivided into the "young old," 65-74 years, "middle old" 75-84 years, and the "old old," 85 years or older. But further subdivisions are needed: persons with only epilepsy, those with epilepsy and multiple medical problems, and the frail elderly. Thus, when considering therapy, one must tailor the interventions to nine categories: young old healthy, young old with medical problems, frail young old, old healthy, old with medical problems, frail old, old old healthy, old old with medical problems, and frail old old. The prevalence of antiepileptic drug (AED) use in community dwelling elderly is 1.5%; in the nursing home population it is 10%. Surprisingly, 3% have an AED newly prescribed after admission. Overall, 6.2% were using phenytoin, 1.8% carbamazepine, 0.9% valproic acid, 1.7% phenobarbital, and others combined, 1.2%. AEDs rank fifth among all drug categories as a cause of adverse reactions. There are very few data regarding the clinical use of AEDs in the elderly. The paucity of information makes it very difficult to recommend specific AEDs with any confidence that the outcomes will be optimal. An appropriate for elderly healthy may not be appropriate for elderly with multiple medical problems, and in frail elderly variable absorption may be a major problem. One of the major advantages of some newer AEDs is lack of drug interactions. Cost is an advantage of the older AEDs. Regardless of the AED chosen, one must use doses appropriate to the clearance of the drug, and AED levels, especially unbound (free) levels, must be monitored. The elderly nursing home resident may be more frail, be taking many medications, and have several concomitant illnesses, making them difficult to treat. The most commonly used AED, phenytoin, may not be the easiest or safest AED to prescribe in the elderly with multiple medical problems or the frail elderly.Keywords
This publication has 15 references indexed in Scilit:
- New Co-Editors-in-Chief for Epilepsy ResearchEpilepsy Research, 2006
- New onset geriatric epilepsyNeurology, 2005
- Tolerability of levetiracetam in elderly patients with CNS disordersEpilepsy Research, 2003
- Antiepileptic drug use in nursing home admissionsAnnals of Neurology, 2003
- Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring dataBritish Journal of Clinical Pharmacology, 1997
- The influence of age on the pharmacokinetics of the antiepileptic agent oxcarbazepineClinical Pharmacology & Therapeutics, 1991
- The effect of age upon liver volume and apparent liver blood flow in healthy manHepatology, 1989
- Plasma Protein Binding of Drugs in the ElderlyClinical Pharmacokinetics, 1987
- Comparison of Carbamazepine, Phenobarbital, Phenytoin, and Primidone in Partial and Secondarily Generalized Tonic–Clonic SeizuresNew England Journal of Medicine, 1985
- Effect of age and sex on the plasma binding of acidic and basic drugsEuropean Journal of Clinical Pharmacology, 1984